{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:06:39Z","timestamp":1648922799230},"reference-count":36,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1684\/bdc.2013.1764","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"765-774","source":"Crossref","is-referenced-by-count":1,"title":["Prise en charge des atteintes m\u00e9tastatiques leptom\u00e9ning\u00e9es des tumeurs solides"],"prefix":"10.1016","volume":"100","author":[{"given":"\u00c9milie","family":"Le Rhun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahed","family":"Zairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2013.1764_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-8118-8-14","article-title":"Detection of cancer cells in the cerebrospinal fluid: current methods and future directions","volume":"8","author":"Weston","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1684\/bdc.2013.1764_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6890-12-21","article-title":"Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis","volume":"12","author":"Le Rhun","year":"2012","journal-title":"BMC Clin Pathol"},{"key":"10.1684\/bdc.2013.1764_bib0015","series-title":"Neurologic Complications of Cancer","author":"Posner","year":"1995"},{"key":"10.1684\/bdc.2013.1764_bib0020","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"key":"10.1684\/bdc.2013.1764_bib0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3171\/2012.1.JNS111560","article-title":"Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection","volume":"116","author":"Ahn","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1684\/bdc.2013.1764_bib0030","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases","volume":"113","author":"Lin","year":"2008","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1764_bib0035","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-011-0592-7","article-title":"Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study","volume":"105","author":"Le Rhun","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and outcome","volume":"104","author":"de Azevedo","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis \u2014 the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-009-9940-2","article-title":"Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy","volume":"95","author":"Clatot","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","article-title":"Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations","volume":"129","author":"Lee","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1684\/bdc.2013.1764_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","article-title":"A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer","volume":"113","author":"Le Rhun","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2011.11.022","article-title":"Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era","volume":"76","author":"Park","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1684\/bdc.2013.1764_bib0085","first-page":"1010","article-title":"Prognostic factors and outcomes in patients with leptomeningeal melanomatosis","volume":"10","author":"Harstad","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0090","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","article-title":"Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment","volume":"36","author":"Chamberlain","year":"2009","journal-title":"Sem Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0095","first-page":"305","article-title":"New strategies in the management of leptomeningeal metastases","volume":"67","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1684\/bdc.2013.1764_bib0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-010-0831-x","article-title":"Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis","volume":"136","author":"Oechsle","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","article-title":"Leptomeningeal metastasis: survival and prognosis in 155 patients","volume":"223","author":"Herrlinger","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1684\/bdc.2013.1764_bib0110","doi-asserted-by":"crossref","first-page":"644","DOI":"10.6004\/jnccn.2005.0038","article-title":"Central nervous system cancers: clinical practice guidelines in oncology","volume":"3","author":"Brem","year":"2005","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1684\/bdc.2013.1764_bib0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis, Eastern Cooperative Oncology Group","volume":"11","author":"Grossman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0120","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0125","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2013.1764_bib0130","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2013.1764_bib0135","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/jco.2006.24.18_suppl.1528","article-title":"A randomized phase III\/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis","volume":"18","author":"Shapiro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0140","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2013.1764_bib0145","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/CAD.0b013e32830b58b0","article-title":"Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER-2 overexpressing metastatic breast cancer: a case report","volume":"19","author":"Stemmler","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1684\/bdc.2013.1764_bib0150","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.11449","article-title":"Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis","volume":"97","author":"Cole","year":"2003","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1764_bib0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","article-title":"Carcinomatous meningitis secondary to nonsmall cell lung cancer: combined modality therapy","volume":"55","author":"Chamberlain","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1684\/bdc.2013.1764_bib0160","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","article-title":"Ventriculoperitoneal shunt in patients with leptomeningeal metastases","volume":"64","author":"Omuro","year":"2005","journal-title":"Neurology"},{"key":"10.1684\/bdc.2013.1764_bib0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3171\/2011.5.JNS101768","article-title":"Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study","volume":"115","author":"Lin","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1684\/bdc.2013.1764_bib0170","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","article-title":"Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis","volume":"116","author":"Glantz","year":"2010","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1764_bib0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-010-0474-4","article-title":"Complications related to the placement of an intraventricular chemotherapy device","volume":"104","author":"Zairi","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1684\/bdc.2013.1764_bib0180","first-page":"65","article-title":"Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006","volume":"15","author":"Varhabhatla","year":"2012","journal-title":"Pain Physician"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:28:39Z","timestamp":1602491319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115303246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0007455115303246"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2013.1764","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}